About Us
Leveraging Standard Identifiers To Provide Value
Pharmaceutical manufacturers, distributors, and dispensers use standard product identifiers to track and trace sellable units through the supply chain.
However once empty of product, this information is rarely utilized to dispose of the container and there is no feedback mechanism to the originating manufacturers of its final disposition.
As states like Maine, Oregon and Colorado pass Extended Producer Responsibility laws, the intersection between serialized product information, decommissioning and sustainability becomes clear.
Decommissioning
We designed-built systems and processes to image, adjudicate, and shred empty, sellable units, curbside at the dispenser's location.
Modalities
DecomRx patented process spans a range modalities to process empty serialized pharmaceutical units.
Decommissioning Event Data
Decommissioning event data is comprised of
Serialized Product Information (SPI), which includes
GTIN, Serial Number, Lot, Expiration.
GTIN contains NDC which includes the Labeler code that identifies
the drug manufacturer. Event data also includes time-date, location and high-definition image to create a proof-positive record of decommissioning.
Near Real-Time Data
Decommissioning event data at your fingertips.
No need to wait weeks or months for market intelligence.
The data is there when you need it.
Value Propositions
Permanently removing sensitive packaging materials from the supply chain and creating a digital record of the event can help reduce cost, improve service and promote sustainability.
DecomRx has exercised several interesting use cases spanning
Brand Management and Brand Protection,
Supply Chain Visibility and Quality.
Industry Experience
Thomas’ corporate experiences include positions at
Johnson & Johnson Supply Chain and Wyeth Pharmaceuticals,
General Electric Company and Andersen Consulting.
At Johnson & Johnson, Thomas and his teammates delivered enterprise product serialization and traceability systems and processes
on-time and on-budget to ensure uninterrupted product supply to patients in the US and 46 other countries.
Thomas' entrepreneurial experience includes ReclaimRx Corporation,
which he founded in 2008 as a research endeavor to
decommission serialized sellable units and
was awarded two US patents for his work.
In 2019, Thomas renamed and relaunched the business as
DecomRx Corporation to bring decommissioning
products and services to industry.
Education
BA Williams College
MBA Fordham University
MS Temple University School of Pharmacy
Certification
Lean Six Sigma, Villanova University
Blockchain, MIT Sloan School of Management
Intellectual Property
U.S.Patents 8,542,099 and 10,062,049
Systems and Processes for Tracking Items